Publications by authors named "Dominik Barth"

Claim this Profile
A
Arterial thromboembolic events in testicular cancer patients: short- and long-term incidence, risk factors, and impact on mortality.
Florian Moik, Angelika Terbuch, Ariane Sprakel, Georg Pichler, Dominik A Barth

J Thromb Haemost· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Evidence for Enfortumab Vedotin in Patients with Metastatic Urothelial Cancer: An Austrian Multicentre Study.
Dora Niedersuess-Beke, Karl Mayrhofer, Johanna Krauter, Susanne Schnabel, Simon Peter Gampenrieder, Dominik Barth

Clin Genitourin Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Change in C-Reactive Protein and Venous Thromboembolism in Patients Treated With Immune Checkpoint Inhibitors.
Florian Moik, Jakob M Riedl, Dominik Barth, Franziska Berton, Michael Fink

JACC CardioOncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort study.
Dominik A Barth, Florian Moik, Sarah Steinlechner, Florian Posch, Marie-Christina Mayer

J Immunother Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex hormones influence survival of patients with metastatic urothelial carcinoma undergoing immune checkpoint therapy.
Andrea Katharina Lindner, Felizian Lackner, Piotr Tymoszuk, Dominik Andreas Barth, Andreas Seeber

Biol Sex Differ· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative fibrinogen/CRP score predicts survival in upper urothelial tract carcinoma patients undergoing radical curative surgery.
Valentina Egger, Georg C Hutterer, Johannes Mischinger, Maximilian Seles, Renate Pichler, Dominik A Barth

World J Urol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma.
Renate Pichler, Peter J Siska, Piotr Tymoszuk, Agnieszka Martowicz, Gerold Untergasser, Dominik A Barth

Front Immunol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of Urinary MiR-501 and MiR-335 With Current Clinical Diagnostic Parameters as Potential Predictive Factors of Prostate Biopsy Outcome.
Jaroslav Juracek, Marie Madrzyk, Karolina Trachtova, Michaela Ruckova, Julia Bohosova, Dominik A Barth

Cancer Genomics Proteomics· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A tissue miRNA expression pattern is associated with disease aggressiveness of localized prostate cancer.
Jaroslav Juracek, Marie Madrzyk, Michal Stanik, Michaela Ruckova, Karolina Trachtova, Dominik A Barth

Prostate· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of postoperative surveillance protocols in upper tract urothelial cancer: A retrospective cohort study.
Andrea Katharina Lindner, Martin Pichler, Sarah Maier, Hanno Ulmer, Thomas Gorreri, Dominik A Barth

Front Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of allogeneic red blood cell transfusion on prognosis in soft tissue sarcoma patients. A single-centre study.
Maria Anna Smolle, Wolfgang Helmberg, Eva Maria Matzhold, Dominik Andreas Barth, Nazanin Sareban

Cancer Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-up.
Hannah Fluhrer, Georg C Hutterer, Sylvia Golbeck, Michael Stidl, Tobias Niedrist, Dominik A Barth

Ther Adv Med Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer study.
Dominik A Barth, Stefanie Stanzer, Jasmin Spiegelberg, Thomas Bauernhofer, Gudrun Absenger

Cancer Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score Analysis.
Franziska Maisel, Maria A Smolle, Stefanie Mollnar, Jakob M Riedl, Dominik A Barth

Clin Genitourin Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-Paclitaxel.
Jakob M Riedl, Esther Schwarzenbacher, Florian Moik, Lena Horvath, Antonia Gantschnigg, Dominik A Barth

Thromb Haemost· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer Study.
Dominik A Barth, Stefanie Stanzer, Jasmin A Spiegelberg, Thomas Bauernhofer, Gudrun Absenger

Front Immunol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging Role of Non-Coding RNAs in Regulation of T-Lymphocyte Function.
Mohammad Taheri, Dominik A Barth, Julia Kargl, Omidvar Rezaei, Soudeh Ghafouri-Fard

Front Immunol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA mimics can distort physiological microRNA effects on immune checkpoints by triggering an antiviral interferon response.
Felix Prinz, Katharina Jonas, Amar Balihodzic, Christiane Klec, Andreas Reicher, Dominik Andreas Barth

RNA Biol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up.
Dominik A Barth, Nazanin Sareban, Andrea K Lindner, Louisa A J Daller, Eva Maria Matzhold

Urol Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis.
Moritz Müller, Florian Posch, Dominik Kiem, Dominik Barth, Lena Horvath

Ther Adv Med Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-200c-3p Modulates Cisplatin Resistance in Biliary Tract Cancer by ZEB1-Independent Mechanisms.
Florian Posch, Felix Prinz, Amar Balihodzic, Christian Mayr, Tobias Kiesslich, Dominik A Barth

Cancers (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis.
Jakob M Riedl, Florian Posch, Lena Horvath, Antonia Gantschnigg, Felix Renneberg, Dominik A Barth

Eur J Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of Long Non-Coding RNAs in Glucose Metabolism in Cancer.
Amar Balihodzic, Dominik A Barth, Felix Prinz, Martin Pichler

Cancers (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The AST/ALT Ratio Is an Independent Prognostic Marker for Disease-free Survival in Stage II and III Colorectal Carcinoma.
Lukas Scheipner, Maria Anna Smolle, Dominik Barth, Florian Posch, Michael Stotz

Anticancer Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-Coding RNAs and SARS-Related Coronaviruses.
Hanna Henzinger, Dominik A Barth, Christiane Klec, Martin Pichler

Viruses· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis